Current Medicinal Chemistry

Foreword:
pp. 1-1(1)
Author: Atta-ur-Rahman

Editorial (Thematic Issue: Current Status and Progress of Radiopharmaceuticals for Molecular Imaging and Targeted Therapy)
pp. 2-3(2)
Author: Zhang, Junbo

Asialoglycoprotein Receptor-Targeted Radiopharmaceuticals for Measurement of Liver Function
pp. 4-23(20)
Authors: Yang, W.; Zhang, X.; Liu, Y.

Radiolabeled Glucose Derivatives for Tumor Imaging Using SPECT and PET
pp. 24-34(11)
Authors: Liu, T.; Zhang, J.; Wang, X.; Yang, J.; Tang, Z.; Lu, J.

Molecular Imaging of σ1 Receptors In Vivo: Current Status and Perspectives
pp. 35-69(35)
Authors: Brust, P.; Deuther-Conrad, W.; Lehmkuhl, K.; Jia, H.; Wünsch, B.

PET Radiotracers for Molecular Imaging of Serotonin 5-HT1A Receptors
pp. 70-81(12)
Authors: Billard, T.; Le Bars, D.; Zimmer, L.

Past and Recent Progress of Molecular Imaging Probes for β-Amyloid Plaques in the Brain
pp. 82-112(31)
Author: Cui, Mengchao

In Vivo Imaging of the Metabotropic Glutamate Receptor 1 (mGluR1) with Positron Emission Tomography: Recent Advance and Perspective
pp. 113-123(11)
Authors: Li, Songye; Huang, Yiyun

Multifunctional Radiolabeled Nanoparticles for Targeted Therapy
pp. 124-138(15)
Authors: Ferro-Flores, G.; E. Ocampo-García, B.; L. Santos-Cuevas, C.; Morales-Avila, E.; Azorín-Vega, E.

Peptide-based Radiopharmaceuticals for Targeted Tumor Therapy
pp. 139-152(14)
Authors: Dong, C.; Liu, Z.; Wang, F.